Did you know that substance-related illnesses cause 637,000 deaths each year in the US (67,300 from overdose) at a cost of over $400 billion? The addictions themselves more often go untreated or under-treated. At the same time, predicting addictions for targeted prevention is almost entirely overlooked.
Let's highlight a few ways that substance misuse leads to illnesses and deaths:
Alcohol causes 88,000 deaths in the US (NIDA). It leads to approximately 144,000 new breast cancer diagnoses, 38,000 annual breast cancer deaths globally, and increases risk of mouth and throat, larynx, esophagus, colon, or liver cancers. 198,000 chronic cardiac conditions can be avoided by eliminating alcohol misuse (per The Journal of the American College of Cardiology).
Nicotine causes 480,000 US deaths, including 41,000 from secondary smoke. (Smokers can expect to live 10 years less than non-smokers.)
I think I've made my point!
If you are a healthcare provider, in the criminal justice system, or employee assistance, please participate in our free 60-day pilot study where you'll have unlimited use of our assessment tool and obtain reports to see the impact this will have on those you serve, as well as on your daily process. To get started, please fill in our
With the current worldwide pandemic, substance-related illnesses and deaths have exponentially increased. We can expect things to get worse unless this devastating chronic illness gets the same standard of care treatment that every other chronic illness gets.
Compris is committed to helping healthcare providers better serve those suffering with addictions by providing the most comprehensive addiction diagnostics and risk-stratification consistent with a chronic illness paradigm.
Compris (French, Com-pree, “understood”) is a 15-20 minute self-report that securely delivers the Compris Profile© to providers within minutes. Compris’ helps mitigate the ongoing addiction epidemic by: 1) predicting addiction risk to help prevent it, 2) offering providers research-based prevention, treatment, and remission-sustaining guidance, including level of care placement and medication selection, 3) supporting increased tele-health treatment access, and 4) Creating an unprecedented research and practice-informing database with machine learning to accelerate our knowledge of how best to treat and manage this devastating chronic illness. Compris’ recommendations target both emergent and ongoing concerns of addiction specialists, ER, acute, and primary care providers, those in criminal justice, the armed services, and employee assistance programs.
For more information please contact us.
Stay healthy and safe.
Joyce and Calvin